Gainers

• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 61.4% to $0.11 during Wednesday's regular session.
• Monte Rosa Therapeutics (NASDAQ:GLUE) shares rose 52.77% to $24.46. The market value of their outstanding shares is at $1.0 billion.
• Innovative Eyewear (NASDAQ:LUCY) shares increased by 51.63% to $1.79. The company's market cap stands at $6.3 million.
• Regencell Bioscience (NASDAQ:RGC) shares moved upwards by 38.05% to $45.6. The company's market cap stands at $16.3 billion.
• Ventyx Biosciences (NASDAQ:VTYX) stock increased by 37.91% to $13.86. The market value of their outstanding shares is at $717.1 million.
• NovaBay Pharmaceuticals (AMEX:NBY) stock rose 36.94% to $10.12. The market value of their outstanding shares is at $931.2 million.

Losers

• ProPhase Labs (NASDAQ:PRPH) shares declined by 18.4% to $0.2 during Wednesday's regular session.
• Cyclerion Therapeutics (NASDAQ:CYCN) shares declined by 14.88% to $1.66. The market value of their outstanding shares is at $7.4 million.
• Curis (NASDAQ:CRIS) stock declined by 13.27% to $0.87. The market value of their outstanding shares is at $12.9 million.
• Park Dental Partners (NASDAQ:PARK) stock declined by 9.11% to $13.08. The company's market cap stands at $58.8 million.
• WORK Medical Tech Gr (NASDAQ:WOK) stock declined by 8.94% to $1.89.
• Theriva Biologics (AMEX:TOVX) stock decreased by 8.91% to $0.22. The company's market cap stands at $8.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.